David Andrew Baker

David Andrew Baker

Auto-generated profile, based on publicly available information

David Andrew Baker

Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2014 in Nature
Verified
Journal Article
Open access
PDF file
BKBjorn Kafsack
Bjorn Kafsack
NRNúria Rovira-Graells
Núria Rovira-Graells
Taane ClarkTaane Clark
Taane Clark
CBCristina Bancells
Cristina Bancells
VCValerie Crowley
Valerie Crowley
MLManuel Llinás
Manuel Llinás
The DNA-binding protein PfAP2-G is found to be a master regulator of sexual development in the malaria parasite; this protein appears to regulate early gametocytogenesis and is epigenetically silenced in the majority of blood-stage parasites. For malaria parasites to be transmitted to the mosquito vector they must undergo sexual development and produce gametocytes. The molecular mechanisms underlying the commitment to gametocyte development have been unclear. Two complementary manuscripts now show that AP2-G, a member of the apicomplexan AP2 family of transcription factors, is a master regulator of sexual development in the malaria parasite, acting as a developmental switch by triggering the transcription of early gametocyte genes. Abhinav Sinha et al. worked with the rodent malaria parasite Plasmodium berghei, and Björn Kafsack et al. with the human pathogen P. falciparum. AP2-G activity in human infectious malaria parasites could be a potential target for antimalarials designed to interfere with gametocyte formation. The life cycles of many parasites involve transitions between disparate host species, requiring these parasites to go through multiple developmental stages adapted to each of these specialized niches. Transmission of malaria parasites (Plasmodium spp.) from humans to the mosquito vector requires differentiation from asexual stages replicating within red blood cells into non-dividing male and female gametocytes. Although gametocytes were first described in 1880, our understanding of the molecular mechanisms involved in commitment to gametocyte formation is extremely limited, and disrupting this critical developmental transition remains a long-standing goal1. Here we show that expression levels of the DNA-binding protein PfAP2-G correlate strongly with levels of gametocyte formation. Using independent forward and reverse genetics approaches, we demonstrate that PfAP2-G function is essential for parasite sexual differentiation. By combining genome-wide PfAP2-G cognate motif occurrence with global transcriptional changes resulting from PfAP2-G ablation, we identify early gametocyte genes as probable targets of PfAP2-G and show that their regulation by PfAP2-G is critical for their wild-type level expression. In the asexual blood-stage parasites pfap2-g appears to be among a set of epigenetically silenced loci2,3 prone to spontaneous activation4. Stochastic activation presents a simple mechanism for a low baseline of gametocyte production. Overall, these findings identify PfAP2-G as a master regulator of sexual-stage development in malaria parasites and mark the first discovery of a transcriptional switch controlling a differentiation decision in protozoan parasites.

9 May 2013 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
CCChristine R Collins
Christine R Collins
FHFiona Hackett
Fiona Hackett
MSMalcolm Strath
Malcolm Strath
MPMaria Penzo
Maria Penzo
CWChrislaine Withers-Martinez
Chrislaine Withers-Martinez
MBMichael J Blackman
Michael J Blackman
The malaria parasite replicates within an intraerythrocytic parasitophorous vacuole (PV). Eventually, in a tightly regulated process called egress, proteins of the PV and intracellular merozoite surface are modified by an essential parasite serine protease called PfSUB1, whilst the enclosing PV and erythrocyte membranes rupture, releasing merozoites to invade fresh erythrocytes. Inhibition of the Plasmodium falciparum cGMP-dependent protein kinase (PfPKG) prevents egress, but the underlying mechanism is unknown. Here we show that PfPKG activity is required for PfSUB1 discharge into the PV, as well as for release of distinct merozoite organelles called micronemes. Stimulation of PfPKG by inhibiting parasite phosphodiesterase activity induces premature PfSUB1 discharge and egress of developmentally immature, non-invasive parasites. Our findings identify the signalling pathway that regulates PfSUB1 function and egress, and raise the possibility of targeting PfPKG or parasite phosphodiesterases in therapeutic approaches to dysregulate critical protease-mediated steps in the parasite life cycle. Malaria is a scourge of the developing world and many researchers are seeking new ways to treat and control the disease. Malaria is caused by a single-celled parasite that grows within red blood cells, eventually rupturing them to release invasive merozoites in a process known as egress. In earlier work we found that, just prior to egress, an enzyme called SUB1 is released from the intracellular parasites into the vacuole in which they reside. SUB1 then cleaves a number of proteins required for egress and development of invasive merozoites. The signals that control SUB1 discharge are poorly understood. In this work, we show that SUB1 release requires the activity of another parasite enzyme called protein kinase G (PKG), which is in turn activated by a small molecule called cGMP. Inhibition of PKG blocks SUB1 discharge and egress, whilst premature activation of PKG by a member of a class of compounds called phosphodiesterase inhibitors, which increase cGMP levels in the parasite, induces premature egress of mostly non-invasive merozoites. These findings increase our understanding of egress and show that both malarial PKG and parasite phosphodiesterases (which are validated drug targets in humans) are potential targets for a new class of antimalarial drugs.

1 September 2005 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
JYJason A. Young
Jason A. Young
QFQuinton L. Fivelman
Quinton L. Fivelman
PBPeter L. Blair
Peter L. Blair
PVPatricia de la Vega
Patricia de la Vega
KRKarine G. Le Roch
Karine G. Le Roch
EWElizabeth A. Winzeler
Elizabeth A. Winzeler

14 May 2010 in Science
Verified
Journal Article
Closed access
PDF file
JDJeffrey D. Dvorin
Jeffrey D. Dvorin
DMDerek C. Martyn
Derek C. Martyn
SPSaurabh D. Patel
Saurabh D. Patel
JGJoshua S. Grimley
Joshua S. Grimley
CCChristine R. Collins
Christine R. Collins
MDManoj T. Duraisingh
Manoj T. Duraisingh
It's a Knockout: The malaria parasite is one of the most important pathogens of humans. Increasing drug-resistance is an imminent public health disaster, and we urgently need to find new drugs. The recently acquired malarial genomes provide a plethora of targets. However, due to the genetic intractability of the parasite, it has been difficult to identify essential genes in the clinically relevant blood-stage of the parasite. Dvorin et al. (p. 910 ) investigated the function of a Plasmodium falciparum plant-like calcium-dependent protein kinase, PfCDPK5, which is expressed in the invasive blood-stage forms of the parasite. A system for conditional protein expression allowed the production of a functional knockout in the bloodstream stage of the parasite. PfCDPK5 was required for parasite egress from the human host erythrocyte, an essential step in the parasite life cycle.

1 July 2007 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
QFQuinton L. Fivelman
Quinton L. Fivelman
LMLouisa McRobert
Louisa McRobert
SSSarah Sharp
Sarah Sharp
CTCathy J. Taylor
Cathy J. Taylor
MSMaha Saeed
Maha Saeed
DBDavid A. Baker
David A. Baker

4 March 2014 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MBMathieu Brochet
Mathieu Brochet
MCMark O Collins
Mark O Collins
TSTerry K Smith
Terry K Smith
ETEloise Thompson
Eloise Thompson
SSSarah Sebastian
Sarah Sebastian
OBOliver Billker
Oliver Billker
Many critical events in the Plasmodium life cycle rely on the controlled release of Ca2+ from intracellular stores to activate stage-specific Ca2+-dependent protein kinases. Using the motility of Plasmodium berghei ookinetes as a signalling paradigm, we show that the cyclic guanosine monophosphate (cGMP)-dependent protein kinase, PKG, maintains the elevated level of cytosolic Ca2+ required for gliding motility. We find that the same PKG-dependent pathway operates upstream of the Ca2+ signals that mediate activation of P. berghei gametocytes in the mosquito and egress of Plasmodium falciparum merozoites from infected human erythrocytes. Perturbations of PKG signalling in gliding ookinetes have a marked impact on the phosphoproteome, with a significant enrichment of in vivo regulated sites in multiple pathways including vesicular trafficking and phosphoinositide metabolism. A global analysis of cellular phospholipids demonstrates that in gliding ookinetes PKG controls phosphoinositide biosynthesis, possibly through the subcellular localisation or activity of lipid kinases. Similarly, phosphoinositide metabolism links PKG to egress of P. falciparum merozoites, where inhibition of PKG blocks hydrolysis of phosphatidylinostitol (4,5)-bisphosphate. In the face of an increasing complexity of signalling through multiple Ca2+ effectors, PKG emerges as a unifying factor to control multiple cellular Ca2+ signals essential for malaria parasite development and transmission. Malaria, caused by Plasmodium spp. parasites, is a profound human health problem. Plasmodium parasites progress through a complex life cycle as they move between infected humans and blood-feeding mosquitoes. We know that tight regulation of calcium ion levels within the cytosol of the parasite is critical to control multiple signalling events in their life cycle. However, how these calcium levels are controlled remains a mystery. Here, we show that a single protein kinase, the cGMP-dependent protein kinase G (PKG), controls the calcium signals that are critical at three different points of the life cycle: (1) for the exit of the merozoite form of the parasite from human erythrocytes (red blood cells), (2) for the cellular activation that happens when Plasmodium sexual transmission stages are ingested by a blood-feeding mosquito, and (3) for the productive gliding of the ookinete, which is the parasite stage that invades the mosquito midgut. We provide initial evidence that the universal role of PKG relies on the production of lipid precursors which then give rise to inositol (1,4,5)-trisphosphate (IP3), a messenger molecule that serves as a signal for the release of calcium from stores within the parasite. This signalling pathway provides a potential target to block both malaria development in the human host and transmission to the mosquito vector.